Molecular Diagnostics

Epigenetic Biomarkers Increase Sensitivity of Prostate Cancer Liquid Biopsy Diagnostic Tests
A team of Austrian researchers identified additional epigenetic biomarkers that will upgrade the diagnosis of advanced prostate cancer by increasing the sensitivity of liquid biopsy analysis of circulating tumor DNA. More...31 Jan 2022


Novel Breath-Based Diagnostics Could Indicate Early Rejection of Organs in Lung Transplant Patients
SQI Diagnostics Inc. (Ontario, Canada) and Owlstone Medical (Cambridge, UK) have signed a Memorandum of Understanding (MOU) to work together on the discovery, development and commercialization of breath-based biomarkers relating to invasive aspergillus lung infection and lung transplant rejection. More...26 Jan 2022

Melanoma Test Offers Reassurance of Low Risk of Cancer Spread
Cutaneous melanoma is an aggressive form of skin cancer with an increasing worldwide incidence, particularly in the younger population. Although treatment for patients with metastatic melanoma has improved remarkably in the last decade, principally with targeted therapies and immune checkpoint modulators, there are still no consistently beneficial treatments for patients with metastatic disease. More...25 Jan 2022

New Test That Accurately Measures DNA Damage in Sperm Could Improve Male Infertility Diagnosis
A new test that can measure the amount of DNA damage in sperm with greater accuracy than current tests could significantly improve diagnosis of male infertility, which is more important than ever now that infertility rates are mounting. More...25 Jan 2022

Circulating Small Extracellular Vesicles Provide Liquid Biopsy Biomarkers for Glioblastoma Diagnosis
A recently published paper described the development of a non-invasive liquid biopsy approach for the identification of biomarkers that could significantly improve glioblastoma (GB) diagnosis and, consequently, patients’ prognosis and quality of life. More...24 Jan 2022

In Other News
Qiagen Launches Portfolio of Environmentally Friendly Nucleic Acid Extraction Kits
New NGS Assay Rapidly Detects Any of Hundreds of Infectious Bacteria from Single Test Run
Fujirebio Europe Launches RoboBlot Instrument for Fully Automated Processing of INNO-LIA Score Assays
New CRISPR-Based Assay Detects Biomarker of Kidney Transplant Rejection in Urine
Fastest DNA Sequencing Technique Diagnoses Rare Genetic Diseases in Mere Hours
Cell-free RNA Profiles Gauge Preeclampsia Risk Months Before Symptoms
MCDA-LFB Assay Developed for Rapid Detection of Legionnaires’ Disease
Tumor Biomarker Panel Improves Identification of Candidates for Lung Cancer Screening
Meridian Receives FDA Clearance for Rapid Fluorescent Immunoassay for Detection of Campylobacter Infection
ddPCR Developed for BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia
Long Mononucleotide Repeat Markers Validated for Microsatellite Instability Detection
Commercial RT-PCR Tests Compared to Culture for Bacterial Gastroenteritis
A Novel Lateral Flow Immunoassay System for Determination of Prostate Specific Antigen
New Color-Coded Test Quickly Reveals If Medical Nanoparticles Deliver Their Payload into Target Cells
Novel Protein Biomarkers Identified for Prostate Cancer Aggressiveness
Menstrual Blood Testing With Capture Sequencing Detects High-Risk Human Papillomavirus
Sex Hormone–Binding Globulin Is a Biomarker for Cardiovascular Disease Risk Independent of Total Testosterone Concentration
Parkinson’s Disease Patients Have More Inflammatory Bacteria in Their Noses
Certain Protein Ectodomains in Cerebrospinal Fluid Are Diagnostic Biomarkers for Autism
Bacterial Communities Diverge in The Lower Airways of CF Children
Intratumor Heterogeneity Analyzed in Neuroblastoma
Epigenetic Biomarkers for Early Rheumatoid Arthritis Detection
Genomic Screening Can Identify Risk for Amyloid Cardiomyopathy
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.







